|
DIS3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.196800E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.542600E-03 |
| Normal-vs-Stage2 |
2.785600E-01 |
| Normal-vs-Stage3 |
1.80129999999279E-05 |
| Normal-vs-Stage4 |
1.5425799999913E-05 |
| Stage1-vs-Stage2 |
6.508600E-01 |
| Stage1-vs-Stage3 |
6.376500E-03 |
| Stage1-vs-Stage4 |
8.918600E-03 |
| Stage2-vs-Stage3 |
6.408400E-02 |
| Stage2-vs-Stage4 |
5.428000E-02 |
| Stage3-vs-Stage4 |
8.582200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.380300E-04 |
| Normal-vs-AfricanAmerican |
1.557890E-04 |
| Normal-vs-Asian |
3.299000E-01 |
| Caucasian-vs-AfricanAmerican |
2.116200E-01 |
| Caucasian-vs-Asian |
7.536600E-01 |
| AfricanAmerican-vs-Asian |
3.687200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.46499999999594E-05 |
| Normal-vs-Female |
1.008080E-02 |
| Male-vs-Female |
8.699800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.794500E-04 |
| Normal-vs-Age(41-60Yrs) |
3.339100E-03 |
| Normal-vs-Age(61-80Yrs) |
3.591400E-04 |
| Normal-vs-Age(81-100Yrs) |
5.702500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.011400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.984000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.107200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.497200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.528800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.097800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.618200E-01 |
| Normal-vs-Grade 2 |
8.015500E-02 |
| Normal-vs-Grade 3 |
4.42190000005116E-06 |
| Normal-vs-Grade 4 |
1.09259999936384E-08 |
| Grade 1-vs-Grade 2 |
4.107000E-01 |
| Grade 1-vs-Grade 3 |
1.821650E-02 |
| Grade 1-vs-Grade 4 |
8.805200E-04 |
| Grade 2-vs-Grade 3 |
9.168200E-04 |
| Grade 2-vs-Grade 4 |
1.49699999996145E-06 |
| Grade 3-vs-Grade 4 |
2.349900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.967600E-01 |
| Normal-vs-ccB subtype |
7.39119999981774E-07 |
| ccA subtype-vs-ccB subtype |
7.02589999512782E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.041700E-04 |
| Normal-vs-N1 |
9.960000E-03 |
| N0-vs-N1 |
4.298600E-01 |
|
|
